Fact is the economic incentive to falsify product is simply too great for a total clean slate. There will always be rogue players driven by essentially criminal intent. Then there is simply poor quality control at varying points along the supply chain. Question is: How effectively are these problems being addressed?
“Some raw materials are rare or difficult to find and in that case if you have a market demand and a product difficult to find, you may find difficulty to have the right botanical to start with,” said Antoine Bily, global R&D director at Naturex in France.
“So you can have some economic adulteration and also some adulteration due to the fact that some plants that are mixed up at the beginning of the process.”
While the problems are universal, the methods of detecting them differ.
Bily said Naturex possessed a “full set of testing methods” to ensure incoming materials were authentic.
Christian Artaria, marketing director at Indena in Italy, said the European Pharmacopeia methods were important and validated methods and, “should be the methods to be followed.”
Holger Riemensperger, general manager of the Health Business Unit at Swiss-based Frutarom agreed the European Pharmacopeia was key and such methods had played a role in reducing the incidence of adulteration.
“Absolutely. It’s pretty much the same for Frutarom. We have a history coming from pharmaceuticals. We apply generally the pharmacopeia for all our raw materials.”
Artaria said adulteration incidents had decreased due to GMP implementation in the US. “Companies now at least have to do identification tests. So it is getting better.”
Supply chain control